PUBLISHER: The Business Research Company | PRODUCT CODE: 1946547
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946547
Microwave ablation (MWA) devices are minimally invasive medical instruments that utilize high-frequency microwave energy to destroy abnormal tissues. These devices generate heat to induce coagulative necrosis, effectively targeting malignant or diseased tissues. This technique offers benefits such as shorter surgical times, minimal damage to surrounding tissues, and quicker patient recovery.
The primary product types of microwave ablation devices include portable wireless ultrasound devices and handheld ultrasound devices. Portable wireless ultrasound devices are compact, wireless imaging tools that offer real-time visualization during procedures, making them suitable for emergency, outpatient, or remote settings. These devices operate using various technologies such as pulsed echo, continuous wave, and thermal ultrasound, with frequency ranges that include low frequency (1-5 megahertz), high frequency (5-15 megahertz), and very high frequency (above 15 megahertz). They are used in a wide range of applications, including oncology, cardiovascular, urology, orthopedic, and others, and are utilized by various end-users such as hospitals, clinics, ambulatory surgical centers, and diagnostic centers.
Tariffs have influenced the microwave ablation devices market by increasing the cost of imported high-precision components and manufacturing equipment, particularly affecting segments like handheld and portable devices. Regions such as North America and Europe, which rely on imports for advanced ablation systems, face higher operational costs, while Asia-Pacific manufacturers experience competitive advantages in local production. Despite cost pressures, tariffs are encouraging companies to localize manufacturing, optimize supply chains, and innovate more cost-efficient devices, potentially boosting domestic market resilience.
The microwave ablation devices market research report is one of a series of new reports from The Business Research Company that provides microwave ablation devices market statistics, including microwave ablation devices industry global market size, regional shares, competitors with a microwave ablation devices market share, detailed microwave ablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the microwave ablation devices industry. This microwave ablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The microwave ablation devices market size has grown rapidly in recent years. It will grow from $0.47 billion in 2025 to $0.52 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to rising prevalence of liver and lung cancers, increasing adoption of radiofrequency ablation techniques, limited availability of advanced surgical options, technological advancements in medical imaging, growing hospital infrastructure in developed regions.
The microwave ablation devices market size is expected to see rapid growth in the next few years. It will grow to $0.77 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing preference for minimally invasive procedures, integration of ai and imaging technologies, rising geriatric population, expansion of healthcare facilities in emerging markets, demand for faster patient recovery and reduced hospitalization. Major trends in the forecast period include minimally invasive treatment adoption, thermal energy optimization, real-time imaging integration, outpatient procedure growth, device miniaturization.
The rising incidence of cancer is expected to drive the growth of the microwave ablation devices market in the coming years. Cancer is a condition in which abnormal cells grow uncontrollably and may spread to other parts of the body. The increase in cancer cases is primarily attributed to higher life expectancy, which raises the risk of developing age-related diseases like cancer. Microwave ablation devices are used in cancer treatment by emitting electromagnetic waves that generate heat to destroy tumor cells. This targeted and minimally invasive method helps preserve healthy tissue and enables faster recovery. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental agency, projected that by 2050, there would be over 35 million new cancer cases, a 77% rise compared to the estimated 20 million cases in 2022. As a result, the growing number of cancer cases is contributing to the expansion of the microwave ablation devices market.
Key players in the microwave ablation devices market are focusing on the development of advanced products with regulatory approvals, such as high-precision microwave ablation systems, to enhance outcomes in minimally invasive cancer treatments. These systems use focused microwave energy to precisely destroy tumor tissue while minimizing damage to surrounding healthy structures, thereby improving safety and therapeutic effectiveness. For instance, in January 2024, Hygea Medical Technology Co. Ltd., a China-based medical device manufacturer, received clearance from the U.S. Food and Drug Administration (FDA) for its EXCEED microwave treatment system and EXACT series microwave ablation probe. This followed prior approval from the National Medical Products Administration (NMPA) in China and was achieved through an expedited review. The FDA's approval confirms the safety, performance, and quality of Hygea's products for treating solid tumors in soft tissues, marking a significant step in the company's international market expansion, particularly in the U.S., a key market for microwave ablation technologies. The system complements current cancer therapies by offering a high-precision, minimally invasive thermal ablation option.
In July 2024, Creo Medical Group plc, a UK-based developer of flexible microwave ablation devices, partnered with Intuitive Surgical Inc. to advance the treatment of lung cancer using minimally invasive techniques. This collaboration aims to integrate Creo's MicroBlate Flex and Kamaptive technology with Intuitive's Ion Endoluminal System to support expanded clinical research and improve precision in lung cancer diagnosis and ablation across the UK and Europe. Intuitive Surgical Inc. is a US-based leader in minimally invasive care and a pioneer in robotic-assisted surgery.
Major companies operating in the microwave ablation devices market are Medtronic plc, Johnson And Johnson Services Inc., Boston Scientific Corporation, AngioDynamics Inc., MicroPort Scientific Corporation, Olympus Corporation, HealthTronics Inc., NeuWave Medical Inc., Perseon Medical BV, Emprint Microwave Ablation System Division, Symple Surgical Inc., MedWaves Inc., TATO Medical Systems, Avecure BV, Surblatec SA, Miramar Labs Inc., Chongqing Haifu Medical Technology Co Ltd, Eco Microwave Inc., Shanghai AOHUA Photoelectric Endoscope Co Ltd, Nanjing Vishee Medical Technology Co Ltd, Hangzhou Wenda Medical Instruments Co Ltd, Medsphere International
North America was the largest region in the microwave ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microwave ablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the microwave ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The microwave ablation devices market consists of revenues earned by entities by providing services such as minimally invasive treatment, localized treatment, support for repeat procedures, and image-guided ablation procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The microwave ablation devices market includes sales of ablation antennas, coaxial cable, control console, and cooling system. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Microwave Ablation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses microwave ablation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for microwave ablation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microwave ablation devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.